Digital Papillary Adenocarcinoma in Nonacral Skin

Digital papillary adenocarcinoma (DPA) is a rare sweat gland neoplasm that has exceptionally been reported outside acral locations. Recently, human papillomavirus 42 was identified as the main oncogenic driver of DPA. Herein, we report 5 tumors arising in extra-acral locations predominantly in the female anogenital skin. Four patients were female and 1 patient was male. The mean age at the diagnosis time was 65 years (range: 55 to 82 y). Tumors were located on the vulva (n=3), perianal area (n=1), and forearm (n=1). Histologically, all tumors were lobular and mainly solid and composed of sheets of cells with rare focal papillae and frequent glandular structures in a "back-to-back" pattern and lined by atypical basophilic cells. Immunohistochemistry showed diffuse positivity for SOX10. Epithelial membrane antigen and carcinoembryonic antigen highlighted the luminal cells and staining for p63 and p40 revealed a consistent and continuous myoepithelial component around glandular structures. Follow-up was available in 3 cases (mean duration: 12 mo [range: 8 to 16 mo]). One patient developed local recurrence and 1 experienced regional lymph node metastases. HPV Capture Next-generation sequencing revealed the presence of the HPV42 genome in all samples. Viral reads distributions were compatible in the 5 cases with an episomal nature of the viral genome, with a recurrent deletion in theE1and/orE2open reading frames. In conclusion, this study demonstrates that digital DPA may rarely present in nonacral locations mainly in the female anogenital area, usually with a more solid pattern as compared with those cases presenting on the digits and it is also associated with HPV42.

[1]  B. Smoller,et al.  Two distinct pathogenic pathways of digital papillary adenocarcinoma — BRAF mutation or low‐risk HPV infection , 2023, Journal of cutaneous pathology.

[2]  K. Mechtler,et al.  Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell–like Program Conserved in HPV-Positive Cancers , 2022, Cancer discovery.

[3]  Wei Zhang,et al.  The First Human Vulvar Intraepithelial Neoplasia Cell Line with Naturally Infected Episomal HPV18 Genome , 2022, Viruses.

[4]  C. Ariyan,et al.  Association of HPV42 with digital papillary adenocarcinoma and the use of in situ hybridization for its distinction from acral hidradenoma and diagnosis at non-acral sites , 2022, Modern Pathology.

[5]  M. Ladanyi,et al.  Defining Novel DNA Virus-Tumor Associations and Genomic Correlates using Prospective Clinical Tumor/Normal Matched Sequencing Data. , 2022, The Journal of molecular diagnostics : JMD.

[6]  A. Nicolas,et al.  Episomal HPV16 responsible for aggressive and deadly metastatic anal squamous cell carcinoma evidenced in peripheral blood , 2021, Scientific Reports.

[7]  R. Carvajal,et al.  A Case Report of Papillary Digital Adenocarcinoma With BRAFV600E Mutation and Quantified Mutational Burden. , 2020, The American Journal of dermatopathology.

[8]  K. Wiedemeyer,et al.  Clinicopathologic Characterization of Hidradenoma on Acral Sites , 2019, The American journal of surgical pathology.

[9]  Théo Z. Hirsch,et al.  Adeno-associated virus in the liver: natural history and consequences in tumour development , 2019, Gut.

[10]  C. Bakal,et al.  ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma , 2019, Nature Communications.

[11]  T. Knackstedt,et al.  Aggressive Digital Papillary Adenocarcinoma: Population-Based Analysis of Incidence, Demographics, Treatment, and Outcomes , 2018, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[12]  Jau-Yu Liau,et al.  BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin. , 2017, Human pathology.

[13]  M. Battistella,et al.  Aggressive digital papillary adenocarcinoma: A clinicopathological study of 19 cases , 2017, Journal of the American Academy of Dermatology.

[14]  Jia Liu,et al.  Viral E6 is overexpressed via high viral load in invasive cervical cancer with episomal HPV16 , 2017, BMC Cancer.

[15]  Nicolas Wentzensen,et al.  Carcinogenic human papillomavirus infection , 2016, Nature Reviews Disease Primers.

[16]  Y. Sheen,et al.  Frequent PIK3CA-activating mutations in hidradenoma papilliferums. , 2016, Human pathology.

[17]  A. M. Konstantinova,et al.  Hidradenoma Papilliferum: A Clinicopathologic Study of 264 Tumors From 261 Patients, With Emphasis on Mammary-Type Alterations , 2016, The American Journal of dermatopathology.

[18]  A. Değer,et al.  Aggressive papillary adenocarcinoma on atypical localization , 2016, Medicine.

[19]  A. Nicolas,et al.  Mechanistic signatures of HPV insertions in cervical carcinomas , 2016, npj Genomic Medicine.

[20]  L. Cerroni,et al.  “Apocrine Hidrocystoma and Cystadenoma”–like Tumor of the Digits or Toes: A Potential Diagnostic Pitfall of Digital Papillary Adenocarcinoma , 2016, The American journal of surgical pathology.

[21]  A. Warth,et al.  Mutations in genes encoding PI3K‐AKT and MAPK signaling define anogenital papillary hidradenoma , 2016, Genes, chromosomes & cancer.

[22]  D. Ivan,et al.  Next-generation sequencing reveals rare genomic alterations in aggressive digital papillary adenocarcinoma. , 2015, Annals of diagnostic pathology.

[23]  N. Muñoz,et al.  The Occasional Role of Low-risk Human Papillomaviruses 6, 11, 42, 44, and 70 in Anogenital Carcinoma Defined by Laser Capture Microdissection/PCR Methodology: Results From a Global Study , 2013, The American journal of surgical pathology.

[24]  A. Lazar,et al.  Cutaneous Digital Papillary Adenocarcinoma: A Clinicopathologic Study of 31 Cases of a Rare Neoplasm With New Observations , 2012, The American journal of surgical pathology.

[25]  A. Iafrate,et al.  A potential role for targeted therapy in a subset of metastasizing adnexal carcinomas , 2011, Modern Pathology.

[26]  N. Muñoz,et al.  Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. , 2010, The Lancet. Oncology.

[27]  A. Agaimy,et al.  Fibroadenoma and Phyllodes Tumors of Anogenital Mammary-like Glands: A Series of 13 Neoplasms in 12 Cases, Including Mammary-type Juvenile Fibroadenoma, Fibroadenoma With Lactation Changes, and Neurofibromatosis-associated Pseudoangiomatous Stromal Hyperplasia With Multinucleated Giant Cells , 2010, The American journal of surgical pathology.

[28]  F. Thierry Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma. , 2009, Virology.

[29]  M. Michal,et al.  Human Papillomavirus in Lesions of Anogenital Mammary-Like Glands , 2007, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[30]  F. Enlund,et al.  Frequent fusion of the CRTC1 and MAML2 genes in clear cell variants of cutaneous hidradenomas , 2007, Genes, chromosomes & cancer.

[31]  O. Hes,et al.  Hidradenoma Papilliferum with Oxyphilic Metaplasia: A Clinicopathological Study of 18 Cases, Including Detection of Human Papillomavirus , 2005, The American Journal of dermatopathology.

[32]  W. Duke,et al.  Aggressive digital papillary adenocarcinoma (aggressive digital papillary adenoma and adenocarcinoma revisited). , 2000, The American journal of surgical pathology.

[33]  S. Beaudenon,et al.  Plurality of genital human papillomaviruses: characterization of two new types with distinct biological properties. , 1987, Virology.

[34]  E. B. Helwig,et al.  Aggressive digital papillary adenoma and adenocarcinoma. A clinicopathological study of 57 patients, with histochemical, immunopathological, and ultrastructural observations , 1987, Journal of cutaneous pathology.

[35]  T. Jouary,et al.  [Creation, implementation and objectives of CARADERM, a national network for rare skin carcinomas - Adnexal neoplasm part]. , 2019, Annales de dermatologie et de venereologie.